Share Twitter LinkedIn Facebook Email Andre Goy, MD, Chairman, John Theurer Cancer Center, Part of @HackensackUMC offers impressions of the TRANSCEND-CLL-004 data investigating the use of CAR-T cell therapy in diffuse large B-cell lymphoma (DLBCL).